The Global Leptospirosis Market is expected to grow at a 6.0% CAGR during the forecast period for 2024-2031.
Leptospirosis is a bacterial infection caused by the bacterium Leptospira. The bacterium is present in the kidneys of several mammals. When contaminated animal poo material is present in the soil and water, it spreads to humans through skin breaks such as cuts, open sores, or dry places. It spreads through the nose, mouth, and genitals, but contracting it from another person is challenging; however, it can be transmitted via physical contact or nursing.
The global leptospirosis market was studied and is predicted to expand significantly throughout the forecast period. Leptospirosis is a condition caused by the bacteria Leptospira. The bacteria are common in soil and water, and contact with contaminated urine or tissue can spread to humans and animals.
Conversely, the high cost of treatment will hamper the market's growth rate. In emerging economies, a lack of experienced personnel and a lack of healthcare infrastructure would provide challenges to the leptospirosis industry. Furthermore, there needs to be more clinical suspicion and limitations to diagnostic capacity and public awareness.
The Leptospirosis market is segmented based on drug, route of administration and distribution channel. The drug market is segmented into Amoxicillin, azithromycin, cefixime, and doxycycline. The other drug segment includes ceftriaxone and penicillin. The route of administration segment includes oral, parenteral, and intravenous. Distribution channel segment includes hospital pharmacies, retail pharmacies, and online pharmacies.
The amoxicillin category will hold a major share of the global Leptospirosis market. This is attributed to the growth in the usage of Amoxicillin for the treatment of Leptospirosis based on guidelines provided by government agencies. Penicillin antibiotic amoxicillin. It treats bacterial illnesses like lung infections (like pneumonia) and dental abscesses. It can also treat stomach ulcers in conjunction with other antibiotics and medications.
The hospital pharmacies segment is projected to grow rapidly in the global Leptospirosis market. In severe cases, such as jaundice, renal failure, or pulmonary hemorrhage, Leptospirosis necessitates hospitalization and extensive treatment.
The North American Leptospirosis market is expected to record the highest market share in revenue shortly. Due to increased leptospirosis epidemics, increased awareness of bacterial illnesses, the existence of medication manufacturers, and increased natural catastrophes resulting in bacterial pollution and zoonosis. For example, according to statistics supplied by the Centres for Disease Control and Prevention in 2022, the United States suffered leptospirosis epidemics in 2021 due to floods in Hawaii, Florida, and Puerto Rico.
Furthermore, according to a study titled "Leptospirosis in the Elderly: the Role of Age as a Predictor of Poor Outcomes in Hospitalised Patients," publicized in the National Library of Medicine in 2020, the hospitalization rate for Leptospirosis in the United States was higher for elderly patients when compared to younger individuals, particularly those under the age of 20.
|
Report Attribute |
Specifications |
|
Growth rate CAGR |
CAGR of 6.0 % from 2023 to 2031 |
|
Quantitative units |
Representation of revenue in US$ billion and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
|
Segments Covered |
By Drug, By Route of Administration, By Distribution Channel, and By Region |
|
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South Korea; Southeast Asia |
|
Competitive Landscape |
USAntibiotics, Dr. Reddy's Laboratories Ltd., Century Pharmaceuticals Ltd., Mayne Pharma Group Limited, Sun Pharmaceutical Industries, Inc., Arlington Pharma, F. Hoffmann-La Roche Ltd, Pfizer Inc., Sandoz International GmbH, ISKON REMEDIES & GMT, Haustus Biotech Pvt. Ltd., and Aden Healthcare. |
|
Customization scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing and available payment methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Leptospirosis Market Snapshot
Chapter 4. Global Leptospirosis Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis of Metaverse Industry
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact on Metaverse Industry
Chapter 5. Market Segmentation 1: by Drug Estimates & Trend Analysis
5.1. by Drug & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Drug:
5.2.1. Amoxicillin
5.2.2. Azithromycin
5.2.3. Cefixime
5.2.4. Doxycycline
5.2.5. Others (Ceftriaxone, Penicillin among others)
Chapter 6. Market Segmentation 2: by Route of Administration Estimates & Trend Analysis
6.1. by Route of Administration & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Route of Administration:
6.2.1. Oral
6.2.2. Parenteral
6.2.3. Intravenous
Chapter 7. Market Segmentation 3: by Distribution Channel Estimates & Trend Analysis
7.1. by Distribution Channel & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Distribution Channel:
7.2.1. Hospital Pharmacies
7.2.2. Retail Pharmacies
7.2.3. Online Pharmacies
Chapter 8. Leptospirosis Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Leptospirosis Market Revenue (US$ Million) Estimates and Forecasts by Drug, 2024-2031
8.1.2. North America Leptospirosis Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
8.1.3. North America Leptospirosis Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
8.1.4. North America Leptospirosis Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Leptospirosis Market Revenue (US$ Million) Estimates and Forecasts by Drug, 2024-2031
8.2.2. Europe Leptospirosis Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
8.2.3. Europe Leptospirosis Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
8.2.4. Europe Leptospirosis Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Leptospirosis Market Revenue (US$ Million) Estimates and Forecasts by Drug, 2024-2031
8.3.2. Asia Pacific Leptospirosis Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
8.3.3. Asia-Pacific Leptospirosis Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
8.3.4. Asia Pacific Leptospirosis Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.4. Latin America
8.4.1. Latin America Leptospirosis Market Revenue (US$ Million) Estimates and Forecasts by Drug, 2024-2031
8.4.2. Latin America Leptospirosis Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
8.4.3. Latin America Leptospirosis Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
8.4.4. Latin America Leptospirosis Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Leptospirosis Market Revenue (US$ Million) Estimates and Forecasts by Drug, 2024-2031
8.5.2. Middle East & Africa Leptospirosis Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2031
8.5.3. Middle East & Africa Leptospirosis Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
8.5.4. Middle East & Africa Leptospirosis Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. USAntibiotics
9.2.2. Reddy's Laboratories Ltd.
9.2.3. Century Pharmaceuticals Ltd.
9.2.4. Mayne Pharma Group Limited
9.2.5. Sun Pharmaceutical Industries, Inc.
9.2.6. Ralington Pharma
9.2.7. Hoffmann-La Roche Ltd
9.2.8. Pfizer Inc.
9.2.9. Sandoz International GmbH
9.2.10. ISKON REMEDIES & GMT
9.2.11. Haustus Biotech Pvt. Ltd.
9.2.12. Aden Healthcare
9.2.13. Other Prominent Players
Leptospirosis Market By Drug-
Leptospirosis Market By Route of Administration
Leptospirosis Market By Distribution Channel
Leptospirosis Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
